Erika Gurzeler

483 total citations
14 papers, 231 citations indexed

About

Erika Gurzeler is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Erika Gurzeler has authored 14 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in Erika Gurzeler's work include Lipid metabolism and disorders (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Erika Gurzeler is often cited by papers focused on Lipid metabolism and disorders (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Erika Gurzeler collaborates with scholars based in Finland, Sweden and Netherlands. Erika Gurzeler's co-authors include Seppo Ylä‐Herttuala, Jenni Huusko, Kari Alitalo, Mari Merentie, Annukka M. Kivelä, Marike H. Dijkstra, Suvi E. Heinonen, Pasi Tavi, Atsushi Miyanohara and Andrey Anisimov and has published in prestigious journals such as PLoS ONE, Scientific Reports and European Heart Journal.

In The Last Decade

Erika Gurzeler

13 papers receiving 230 citations

Peers

Erika Gurzeler

CCM

IMMUN

SURGE

Chunyan Luo China

Rachit Badolia United States

Kiyonori Togi Japan

Isabelle Hmitou France

Eddie Han Pin Tan Singapore

Marike H. Dijkstra Finland

Erlinda The United States

Binod Aryal United States

Changming Tan China

Georgios Foteinos United Kingdom

Chunyan Luo China

Erika Gurzeler

149 ×1.1

79 ×0.8

CCM

31 ×0.7

IMMUN

29 ×0.7

SURGE

42 ×1.1

Citations per year, relative to Erika Gurzeler Erika Gurzeler (= 1×) peers Chunyan Luo

Countries citing papers authored by Erika Gurzeler

Since Specialization

Citations

This map shows the geographic impact of Erika Gurzeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Gurzeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Gurzeler more than expected).

Fields of papers citing papers by Erika Gurzeler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Gurzeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Gurzeler. The network helps show where Erika Gurzeler may publish in the future.

Co-authorship network of co-authors of Erika Gurzeler

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Gurzeler. A scholar is included among the top collaborators of Erika Gurzeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Gurzeler. Erika Gurzeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Mallick, Rahul, Erika Gurzeler, Petra Korpisalo, et al.. (2025). VEGF-B is a novel mediator of ER stress which induces cardiac angiogenesis via RGD-binding integrins independent of VEGFR1/NRP activities. Molecular Therapy. 33(7). 3242–3256.

Mallick, Rahul, et al.. (2022). Novel Designed Proteolytically Resistant VEGF-B186R127S Promotes Angiogenesis in Mouse Heart by Recruiting Endothelial Progenitor Cells. Frontiers in Bioengineering and Biotechnology. 10. 907538–907538. 5 indexed citations

Gurzeler, Erika, et al.. (2021). SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice. PLoS ONE. 16(11). e0258408–e0258408. 1 indexed citations

Heinonen, Suvi E., Erika Gurzeler, Lisa M. Berglund, et al.. (2018). In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR^–/–ApoB^100/100 mice. Diabetes and Vascular Disease Research. 15(4). 302–313. 3 indexed citations

Merentie, Mari, Jenni Huusko, Erika Gurzeler, et al.. (2018). Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice. PLoS ONE. 13(1). e0190981–e0190981. 15 indexed citations

Gurzeler, Erika, Einari Aavik, Henri Niskanen, et al.. (2018). Therapeutic effects of rosuvastatin in hypercholesterolemic prediabetic mice in the absence of low density lipoprotein receptor. Biochimica et Biophysica Acta (BBA) - General Subjects. 1863(2). 481–490. 2 indexed citations

Naumenko, Nikolay, Jenni Huusko, Tomi Tuomainen, et al.. (2017). Vascular Endothelial Growth Factor-B Induces a Distinct Electrophysiological Phenotype in Mouse Heart. Frontiers in Physiology. 8. 373–373. 6 indexed citations

Kivelä, Annukka M., Jenni Huusko, Erika Gurzeler, et al.. (2017). High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy. Scientific Reports. 7(1). 386–386. 2 indexed citations

Gurzeler, Erika, Mari Merentie, Jenni Huusko, et al.. (2017). Left ventricular remodeling leads to heart failure in mice with cardiac‐specific overexpression of VEGF‐B₁₆₇: echocardiography and magnetic resonance imaging study. Physiological Reports. 5(6). 15 indexed citations

10.

Theelen, Thomas, Jari P. Lappalainen, Judith C. Sluimer, et al.. (2015). Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice. Atherosclerosis. 241(2). 297–304. 45 indexed citations

11.

Heinonen, Suvi E., Annukka M. Kivelä, Jenni Huusko, et al.. (2013). The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models. Cardiovascular Research. 99(4). 716–723. 51 indexed citations

12.

Kivelä, Annukka M., Suvi E. Heinonen, Pia Leppänen, et al.. (2013). The effects of VEGF-A on atherosclerosis, lipoprotein profile and lipoprotein lipase in hyperlipidemic mouse models. European Heart Journal. 34(suppl 1). P2386–P2386. 1 indexed citations

13.

Kivelä, Annukka M., Marike H. Dijkstra, Suvi E. Heinonen, et al.. (2012). Regulation of endothelial lipase and systemic HDL cholesterol levels by SREBPs and VEGF-A. Atherosclerosis. 225(2). 335–340. 23 indexed citations

14.

Huusko, Jenni, Mari Merentie, Erika Gurzeler, et al.. (2012). AAV9-mediated VEGF-B Gene Transfer Improves Systolic Function in Progressive Left Ventricular Hypertrophy. Molecular Therapy. 20(12). 2212–2221. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact